Loading clinical trials...
Loading clinical trials...
A Phase 1 Placebo-Controlled, Double-Blind Crossover Study to Assess Psychological Effects of MDMA When Administered to Healthy Volunteers
Conditions
Interventions
Lactose (inactive placebo)
midomafetamine HCl
Locations
3
United States
Aguazul Bluewater, Inc.
Boulder, Colorado, United States
Santa Fe MDMA Therapy Training, LLC
Santa Fe, New Mexico, United States
Zen Therapeutic Solutions
Mt. Pleasant, South Carolina, United States
Start Date
April 9, 2011
Primary Completion Date
August 5, 2022
Completion Date
August 5, 2022
Last Updated
October 31, 2024
Lead Sponsor
Lykos Therapeutics
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions